Compare,PMID,Parameter,Sentece,Title,Type,URL,Units,Value,id,Drugbank_id,Name
,489762,half-time,The second rapid elimination phase (beta) had a half-time of 3.4 hours in normal subjects and was insignificantly prolonged to 16.4 hours in renal impairment.,Bethanidine elimination from plasma. ,"t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/489762/),h,3.4,163703,DB00217,Bethanidine
,489762,half-time,The second rapid elimination phase (beta) had a half-time of 3.4 hours in normal subjects and was insignificantly prolonged to 16.4 hours in renal impairment.,Bethanidine elimination from plasma. ,"t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/489762/),h,16.4,163704,DB00217,Bethanidine
,489762,terminal elimination phase,"There was an extended terminal elimination phase of 90 and 70 hours for normals and impaired, respectfully.",Bethanidine elimination from plasma. ,"t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/489762/),h,90,163705,DB00217,Bethanidine
,489762,terminal elimination phase,"There was an extended terminal elimination phase of 90 and 70 hours for normals and impaired, respectfully.",Bethanidine elimination from plasma. ,"t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/489762/),h,70,163706,DB00217,Bethanidine
,489762,volume of distribution,"The volume of distribution at pseudoequilibrium was 2.8 and 1.6 liters/kg, respectively, suggesting significant sequestration of the drug in body tissues.",Bethanidine elimination from plasma. ,V-Q61,[Article Link](https://pubmed.ncbi.nlm.nih.gov/489762/),[l] / [kg],2.8,163707,DB00217,Bethanidine
,489762,volume of distribution,"The volume of distribution at pseudoequilibrium was 2.8 and 1.6 liters/kg, respectively, suggesting significant sequestration of the drug in body tissues.",Bethanidine elimination from plasma. ,V-Q61,[Article Link](https://pubmed.ncbi.nlm.nih.gov/489762/),[l] / [kg],1.6,163708,DB00217,Bethanidine
,1120401,half-lives of the terminal phase,Estimated half-lives of the terminal phase ranged from 7 to 11 hr.,Pharmacokinetics of bethanidine in hypertensive patients. ,"t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/1120401/),h,7 to 11,254406,DB00217,Bethanidine
